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Abstract: With increased development of medical technology (MT), new challenges emerge related
to education and training of pharmacists and other healthcare specialists. Currently, only a few
universities in the EU promote MT education and research. Objectives: The aim of this study
was to evaluate the current status, views on, and need for the education on MT for the pharmacy
students and practicing pharmacists in the Baltic and Nordic countries. Methods: The representatives
of higher education institutions and community/hospital pharmacists from six Baltic and Nordic
countries participated in a qualitative cross-sectional exploratory internet-based study from May
to October 2014. Results: Approximately two-third of the respondents considered professional
knowledge about MT products important for pharmacists, but half of them had never participated
in any MT courses. More practicing pharmacists than representatives of academia underlined the
need for increased MT education for pharmacy students in the future. Conclusions: The pharmacists
in the Baltic and Nordic countries consider the professional knowledge about MT as pertinent in
their education and work. The limited number and status of MT courses available today, however,
is a major concern among both pharmacy students and practicing pharmacists in these countries.
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In the future, increasing education combining theory and practice about MT products would be one
possible solution to overcome this challenge.
Keywords: medical technology; education; pharmacy students; practicing pharmacists;
professional competency
1. Introduction
Medical technology (MT) encompasses a wide range of health care products and is used to
diagnose, monitor or treat diseases or conditions affecting humans. MT covers medical devices
(MDs), drug delivery products (DDPs, medicinal products integrated with device), procedures and
organizational systems used in health care [1].
While there are many potential therapeutic benefits in using MT, this relies on the correct use
of the equipment, and misuse may compromise patient safety. A UK patient safety audit found that
nearly 10% of safety incidents reported from intensive care and high dependency units involved
MDs [2].
In the Baltic and Nordic countries, community and hospital pharmacies are an important source
for counselling and dispensing of MDs and DDPs. Some alternative channels for purchasing personal
MDs include e.g., supermarkets, opticians and regular shops for patches and patient care products,
and special shops for blood pressure monitors and other MT products. Increasingly, people prefer to
buy MDs from pharmacies as they are considered to be preparations closely related to pharmaceutical
products [3,4]. Today, community pharmacies are also a legal distribution source of MT products.
With the implementation of Directive 2011/24/EU on the application of patients' rights in cross-border
health care, community pharmacies are responsible for providing counselling and assuring the safe and
appropriate use of MT products in the same way as for medicinal products [5]. Previous studies suggest
that the proper use of MDs and DDPs can influence medication adherence and illness control [6].
Pharmacists are ideally positioned to educate patients, who use medications associated with MDs and
DDPs [7–11].
With the rapid development of MT, new challenges occur related to education and training of
pharmacists and other healthcare specialists. At present, only few universities promote MT in the
EU through offering postgraduate education and research projects [12,13]. For example, in the UK,
the Sheffield Hallam University in collaboration with the NSF Health Sciences Medical Devices offers
international quality and regulatory training courses, as well as professional qualifications on MD [14].
In the USA, the significance and need for this kind of education have been better recognized [15,16].
The lack of high-level education and training in MT is a major concern since in the future the number
of different medical, biomedical and pharmaceutical services will steadily increase in health care.
Pharmacists will have an important role in delivering and counselling on MT products for patients.
The aim of this cross-sectional exploratory study was to evaluate the current status, views on, and
need for, education provided on MT to pharmacy students and practicing pharmacists in the Baltic
and Nordic countries.
2. Materials and Methods
2.1. Study Design and Sampling
Qualitative electronic survey using a web platform eFormular was employed as a research tool for
data collection in this cross-sectional study. In the Baltic and Nordic countries, all parties involved
with MT education and practice in pharmacy were asked to participate.
The invitation to participate was forwarded to all higher education institutions (HEI) providing
the under- and postgraduate training of pharmacists (MSc Pharm) and assistant pharmacists (BSc
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Pharm) as well to the professional organizations of community and hospital pharmacists (representing
practicing pharmacists). All three Baltic countries—Estonia, Latvia and Lithuania—participated in
the survey. Finland, Iceland and Norway participated from the Nordic countries, while Denmark and
Sweden declined the invitation (Table 1). In all countries the data collection was conducted according
to the general ethical principles of biomedical research. Separate approval from ethics committee was
not required for this type of study (confirmed by the Research Ethics Committee of the University
of Tartu).
Table 1. The higher education institutions (HEIs) and professional organizations involved in the survey.
Country/Total Number
of Respondents HEI/Professional Organization and Respective Number of Responses
Estonia (n = 12)
University of Tartu (n = 3);
Tallinn Health Care College (n = 2);
Estonian Society of Hospital Pharmacists (n = 1);
Estonian Pharmacists’ Association (n = 1);
Estonian Pharmacies Association (n = 1);
Estonian Pharmacy Society (n = 1);
Pharmacy Chain Euroapteek (n = 1);
Community Pharmacy Managers (n = 2)
Finland (n = 6)
University of Helsinki (n = 2);
University of Eastern Finland (n = 2);
Åbo Akademi University (n = 1);
Association of Finnish Pharmacies (n = 1)
Iceland (n = 4)
University of Iceland (n = 2);
The National University Hospital of Iceland (n = 1);
Community Pharmacy Manager (n = 1)
Latvia (n = 9)
University of Latvia (n = 2);
Stradins University (n = 5);
Latvian Pharmacists’ Association (n = 2)
Lithuania (n = 4)
Lithuanian University of Health Sciences (n = 2);
Lithuanian Pharmaceutical Society, Hospital Pharmacy Section (n = 1);
Lithuanian Union of Pharmacists (n = 1)
Norway (n = 15)
University of Oslo (n = 1);
University of Bergen (n = 2);
UiT The Arctic University of Norway (n = 5);
The Nord-Trøndelag University College (n = 5);
The Norwegian Association of Pharmacists (n = 1);
Norwegian Pharmaceutical Students’ Association (n = 1)
2.2. Survey Instrument
The initial ideas regarding the necessity of professional knowledge of MDs and DDPs for
pharmacists were obtained from an earlier national study in Estonia [3,4]. The initial survey instrument
was developed by the panel of researchers at schools of pharmacy in the participating countries.
The specialists in MT (Estonian Health Board) and health statistics as well as the representatives of
community pharmacies (n = 5) were consulted to ensure the content and face validity of the survey
instruments. In the later stage, it was decided to design two separate survey instruments. The first
one was intended for the representatives of academia (teaching staff and students) and the second one
for the professional organizations with some changes in wording. The content of these two survey
instruments, however, was identical. The survey instruments consisted of total 9 multiple choice and
4 non-multiple choice questions on the following topics:
- the importance of professional knowledge about MDs for pharmacists;
- the courses available focusing on MDs and DDPs at universities and for practicing pharmacists;
- the background of specialists providing training about MDs and DDPs at universities and for
practicing pharmacists;
- the future education need about MDs and DDPs for pharmacy students and pharmacists.
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The survey instruments are provided as “supplementary materials”.
2.3. Data Collection
The survey instrument was asked to be completed by academic staff members working with
the development and implementation of pharmacy curriculum as well as by BSc Pharm/MSc Pharm
students at the HEIs. One jointly completed survey instrument from the academic staff members of
each higher education institution was expected to be received. One to two completed joint survey
instruments were asked from the pharmacy students (one from those universities providing only
MSc degree education and two from those giving both BSc and MSc degree education in pharmacy).
Professional organizations received the survey instrument via the university contacts with a request to
complete only one joint survey instrument by representatives of community and hospital pharmacies,
respectively. As shown in Table 1, several completed survey instruments were received from some
participating countries.
2.4. Data Analysis
The data were collected onto eFormular, coded and analyzed by using MS Excel version 14.0.
For the open questions, principles of qualitative content analyses were used [17]. The results have been
grouped in representatives of academia (teaching staff and pharmacy students), and in representatives
of professional associations (community pharmacy and hospital pharmacy) and practicing pharmacists.
Grouping by countries was not used due to uneven representation of the countries in the survey.
3. Results
A total of 50 responses were obtained and analyzed in the survey. All HEIs providing pharmacy
education in the participating countries were represented in the study. Of the professional organizations
or practicing specialists we received at least one joint reply from the community and hospital pharmacy,
except hospital pharmacists from Finland (Table 1). Total 34 respondents were from the academia
(14 teaching staff members and 20 BSc and MSc pharmacy students), and 16 respondents were from
the professional organizations and practicing specialists (11 from the community pharmacy and 5 from
the hospital pharmacy).
According to the respondents, there is a lack of available MT product courses across the Baltic
and Nordic countries. The minor variation in responses between the survey participating countries
could be explained by the differences in the education and practice systems in these countries. About
two-third of the respondents strongly agreed with the claim that professional knowledge about MT
products is important for pharmacists and increases the quality of community pharmacy services.
About two-third of the respondents strongly agreed with the claim that professional knowledge about
MT products is important for pharmacists and increases the quality of community pharmacy services.
3.1. Perceptions of the Current Status of the Courses Available about MT Products
The availability of lectures and courses on MT products for pharmacy students and practicing
pharmacists, according to the representatives of academia, practicing pharmacists and professional
associations, in the Nordic and Baltic countries is presented in Table 2.
Table 2. The availability of specific training about MT products for pharmacy students and practicing
pharmacists in the Nordic and Baltic countries as reported by survey respondents (n = 50).
Students
(n = 20)
Teaching Staff
(n = 14)
Community
Pharmacists (n = 11)
Hospital
Pharmacists (n = 5)
YES NO YES NO YES NO YES NO
General principles of MT products 17 3 10 4 3 8 1 4
Practical use of MDs 10 10 10 4 4 7 1 4
Practical use of DDPs 9 11 10 4 4 7 1 4
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About one fifth of the representatives of professional organizations reported that continuing
education courses, focusing on different aspects of MT products, are available for practicing
pharmacists. Based on the responses of the academia group, teachers seemed more likely than
students to agree that theoretical and practical MT courses are available and more students agree on
availability of theoretical than practical courses about MT products. A short description of compulsory
courses related to MT products in the study countries is presented in the additional information
included to the article.
The representatives of practicing pharmacists including professional organizations described their
views on the existing courses for practicing pharmacists on MT products. The Finnish respondents
reported that there are no general courses available on MDs to date, but for example, in some
asthma-related courses, training about the correct use of inhalation devices is given. Furthermore, some
information about measuring blood pressure is presented in the courses on hypertension. The Estonian
respondents described some specialized courses: practical instructions about the use of DDPs (i.e.,
insulin pens) and diagnostic medical devices (i.e., blood pressure monitors, glucometers).
The Lithuanian respondents described courses on general principles of MT products and the Latvian
respondents courses on the use of glucometers. In both countries, there are also courses on asthma
(including the correct use of inhalators) and on hypertension (including the correct measurement of
blood pressure).
The Icelandic respondents reported that occasionally some medical device companies provide
training events for practicing pharmacists. The respondents from Norway informed that no courses
were available for practicing pharmacists, but at the universities they have a group of students, who
invite industry or other pharmacy-related specialists or health care professionals to give lectures once
or twice per term on a specific topic (i.e., an elective lecture entitled “Asthma inhalers, difficulties and
solutions”, free of charge for pharmacists).
3.2. Perceived Professional Competency of Specialists Providing the Training about MT Products
About half of the practicing pharmacists in community pharmacies and one fifth of the practicing
pharmacists in hospitals reported that the teachers in their continuing education courses were
professionals in the field of MT products (Table 3). In addition, more than half of the representatives of
hospital pharmacists reported that specialists from MT industry and practicing medical doctors and
nurses were involved at the continuing education courses about MDs and DDPs However, over half of
the representatives of community pharmacists named university lecturers without special education of
MTs as common trainers about MT products. University lecturers with no specific education about MT
were named by majority of academia group as frequent providers about information on MT products.
Currently the HEIs in the participating countries do not employ specialists with specific education on
MT. Specialists from other fields may have extended, practical, knowledge in the specific field of MT,
i.e., about the use of blood pressure monitors, inhalators, glucometers, cholesterol meters, hemoglobin
meters and insulin delivery devices.
Table 3. Specialists providing the training on MT for pharmacy students and practicing pharmacists in
the Nordic and Baltic countries by survey respondents (n = 50).
Students
(n = 20)
Teaching Staff
(n = 14)
Community
Pharmacists (n = 11)
Hospital
Pharmacists (n = 5)
YES NO YES NO YES NO YES NO
Specialists in the field of MT * 4 16 5 9 6 5 1 4
University teachers without
specialization on MT 14 6 13 1 7 4 1 4
Representatives of MT industry 6 14 4 10 5 6 3 2
Practicing doctors or nurses 4 16 6 8 5 6 3 2
* MT = medical technology.
Pharmacy 2016, 4, 29 6 of 9
3.3. Educational Perspectives on MT Products in the Future
The majority of the representatives of professional organizations and practicing pharmacists
expressed the urgent need to increase the number of lectures and practical seminars about MT products
for pharmacy students. In the academia group, about half of the respondents shared the same opinion
(Table 4).
Table 4. Opinions about the need to increase the share of MT education for pharmacy students of
survey participants by country (n = 50).
Students
(n = 20)
Teaching
Staff (n = 14)
Community
Pharmacists (n = 11)
Hospital
Pharmacists (n = 5)
To a
great extent 4 2 5 3
considerable extent 8 1 3 1
moderate extent 5 7 3 1
small extent 3 4 - -
Academic and practicing specialists groups considered “teaching the teachers” type of
(international) courses a good solution to increase pharmacy students’ and pharmacists’ professional
competency on MT products. According to all respondents educational courses and seminars could be
organized by regional institutions (universities, hospitals, pharmaceutical companies) and professional
associations as well as European and international organizations, i.e., representative of medical
technology industry in Europe—Eucomed.
4. Discussion
To the best of our knowledge, this is the first international study evaluating the existing status
and need of MT education for pharmacy students and practicing pharmacists (including postgraduate
education). Previous international research has revealed that the corresponding education is
fragmented and may impede the professional competency of community and hospital pharmacists in
counseling of the use of MDs and DDPs [3,4,6–10].
The results of current study support former international studies—there is a lack of available
specific MT product courses across the Baltic and Nordic countries. Currently provided knowledge
about MDs and DDPs for pharmacy students and practicing specialists in the Baltic and Nordic
countries may differ to some extent, and be more theoretical for pharmacy students and covering
mostly detailed practical aspects for pharmacists. For practicing pharmacists, the training is mostly
given by the specialists from the MT industry, nurses and physicians. For pharmacy students, the
education is mostly provided by the university teaching staff without special education in the field of
MT. There is a good example from Norway where students have taken initiative to organize the lectures
and courses by inviting educators from MT industry as well as practicing physicians and nurses.
Described trends could also be seen in the former MT education research, where continuing
education courses oriented on the practical aspects of MT products, i.e., effective and safe use of
DDPs have been mostly studied. Casset et al. (2014) investigated asthma management and inhalation
techniques among community pharmacists in France and compared the results of 1999 and 2009
studies [18]. Within ten years, the health care authorities encouraged the involvement of community
pharmacists in patient care and education in order to improve asthma control. However, knowledge
of asthma management is still average, pointing to the need to join different counselling skills about
disease, the use of medicines and medical devices [18]. Basheti et al. (2009) reported about the need for
continuing education and practice with patient training in order be able better maintain their inhaler
technique demonstration skills [10].
On the other hand, few countries in Europe emphasize the need for theoretical knowledge in
MT. For example, some pharmacy schools in Bulgaria provide separate courses in MDs within the
MSc (Pharm) curriculum in the 5th semester containing total 30 h of studies [19]. According to
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the authors, it has been considered to establish unified state requirements for the present courses
in MT as there is an increased demand for this type of professional knowledge among practicing
pharmacists [19]. In addition, Sakuma (2013) has emphasized that teaching the fundamental framework
of MD regulations and standards is more important than teaching only detailed guidelines for specific
MDs [20]. The authors recommended education through case studies where students can analyze
examples of specific MDs, i.e., approval process and use, as an example of effective methods. These
trainings could be implemented together with research activities conducted by students [20]. In the
future planning of MT education combined approach of theoretical knowledge and practical skills
could be suggested in undergraduate as well as continuing pharmacy education.
This study presented considerable difference in opinions of different respondent groups about
increasing the education of MT products for pharmacy students in the future. While academic staff
and pharmacy students found this knowledge less important, the representatives of professional
organizations and practicing pharmacists would demand more training given during pharmacy
studies about MDs and DDPs. In our previous study, only 15% of community pharmacists in Estonia
indicated university education as relevant source of professional knowledge about MT products [4].
The difference in the opinions of respondents’ groups could be due to the statutory role of practicing
pharmacists in assuring the quality and safety of dispensed MDs and DDPs, and due to their insufficient
professional competency to complete this task. Respondents would value the possibility to have
international courses about MT products and have listed universities, governmental institutions,
international organizations and representatives of pharmaceutical industry as possible providers of
educational courses about MDs.
Based on the results and feedback of this study, we plan to establish the Baltic-Nordic research
cluster together with the leading public and private sector organizations acting in different areas
of pharmacy and healthcare sectors. The main scope of the cluster is to gain understanding of the
challenges related to education, implementation, application and regulation of modern MT innovations
in the health care and society. This knowledge could be used in improving the quality and safety of
MT product related interventions at primary care level and in improving the quality of education
provided on this field for students and practicing specialists.
Study Limitations
In this study, there was an uneven representation of participating countries and respondent
groups. We received more responses from Estonia and Norway, compared to Iceland and Lithuania.
Furthermore, the number of respondents from academia was higher compared to practicing specialists
and representatives of the professional organizations. There were different views and practices about
the MT products in the Baltic and Nordic countries, in addition did Sweden and Denmark decline the
invitation, and thus the full overview of the current available MT education may not have been gained.
In addition, the joint survey protocol used in this study can result in partially skewed information.
5. Conclusions
Based on this cross-sectional exploratory study, the pharmacists in the Baltic and Nordic countries
consider the professional knowledge about MT as relevant in their education and work. However,
the number of specific courses on MDs and DDPs for students and pharmacists are limited, or even
missing in some of the participating Baltic and Nordic countries. Respondents agreed that the basic
knowledge of MT products is a part of professional competency of practicing pharmacists. In the
future, education combining theory and practice about MT products would be an interesting approach
to improve MT knowledge in pharmacies.
Supplementary Materials: The following are available online at http://www.mdpi.com/2226-4787/4/4/29/s1,
Table S1: Compulsory and elective courses about MT products in the Baltic and Nordic countries.
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